 | Apellis Pharmaceuticals (NASDAQ:APLS) Rating Lowered to Sell at BidaskClub
marketbeat.com - July 31 at 5:23 AM |
 | Apellis Pharmaceuticals Inc (NASDAQ:APLS) Given Consensus Recommendation of "Buy" by Brokerages
americanbankingnews.com - August 4 at 2:12 AM |
| Apellis Pharmaceuticals (NASDAQ:APLS) Trading 7.1% Higher
americanbankingnews.com - August 3 at 8:28 PM |
| Apellis Pharmaceuticals (NASDAQ:APLS) Posts Quarterly Earnings Results, Misses Expectations By $0.23 EPS
www.americanbankingnews.com - August 1 at 4:17 PM |
| Zacks: Brokerages Anticipate Apellis Pharmaceuticals Inc (NASDAQ:APLS) to Announce -$1.30 EPS
www.americanbankingnews.com - August 1 at 6:49 AM |
| Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price Down 7.3%
www.americanbankingnews.com - July 31 at 8:50 PM |
 | Apellis Pharmaceuticals EPS misses by $0.23
seekingalpha.com - July 31 at 7:54 AM |
| Apellis Pharmaceuticals (NASDAQ:APLS) Shares Down 4%
www.americanbankingnews.com - July 22 at 4:33 PM |
| Apellis Pharmaceuticals (NASDAQ:APLS) Now Covered by Analysts at Roth Capital
www.americanbankingnews.com - July 20 at 8:20 AM |
| Traders Purchase Large Volume of Apellis Pharmaceuticals Call Options (NASDAQ:APLS)
www.americanbankingnews.com - July 16 at 7:45 AM |
|
| Apellis advances late-stage studies of pegcetacoplan in vision loss disorder
seekingalpha.com - July 7 at 8:36 AM |
 | Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)
finance.yahoo.com - July 7 at 8:36 AM |
| Apellis completes enrollment in late-stage pegcetacoplan study for rare blood disorder
seekingalpha.com - July 2 at 9:38 AM |
| Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
finance.yahoo.com - July 2 at 9:38 AM |
| Hedge Funds Are Selling Apellis Pharmaceuticals, Inc. (APLS)
finance.yahoo.com - June 12 at 9:52 AM |
| Apellis on go to file U.S. application for pegcetacoplan for rare blood disorder
seekingalpha.com - May 21 at 10:02 AM |
| Apellis Announces Plans to Submit NDA for Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH)
finance.yahoo.com - May 21 at 10:02 AM |
| Apellis to Present Pivotal Paroxysmal Nocturnal Hemoglobinuria (PNH) Data at 25th EHA Annual Congress
finance.yahoo.com - May 14 at 1:42 PM |
 | Waltham biopharma plans new stock raise after $400M in January
www.bizjournals.com - May 12 at 4:32 PM |
| Apellis launches $300M convertible debt deal
seekingalpha.com - May 7 at 12:15 PM |
| Apellis Pharmaceuticals Announces Private Placement of Convertible Senior Notes
finance.yahoo.com - May 7 at 12:15 PM |
| Apellis Pharmaceuticals Reports First Quarter 2020 Financial Results
finance.yahoo.com - April 29 at 7:18 PM |
| Apellis Reports Analysis from Phase 1b Geographic Atrophy Study
finance.yahoo.com - April 28 at 8:13 AM |
 | venBio Closes $394 Million Life Sciences Venture Capital Fund
www.marketwatch.com - April 3 at 11:02 AM |
| Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - February 27 at 5:07 PM |
 | Apellis Pharmaceuticals Inc.
www.barrons.com - February 20 at 10:53 PM |
 | Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional
www.bloomberg.com - February 19 at 7:49 PM |
| Alexion Pharmaceuticals: Revising My Valuation
seekingalpha.com - February 7 at 2:46 PM |
| Apellis Pharmaceuticals, Inc. (APLS) vs. Hedge Fund Favorites in 2019
finance.yahoo.com - January 13 at 3:39 PM |
| Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
finance.yahoo.com - January 13 at 3:39 PM |
|
| Apellis Pharmaceuticals Phase 3 Success, And Other News: The Good, Bad, And Ugly Of Biopharma
seekingalpha.com - January 10 at 3:39 PM |
| Apellis Pharmaceuticals is planning to raise $350M — here's how
www.bizjournals.com - January 9 at 10:03 PM |
| Apellis Pharma prices stock offering at $37; shares down 2% premarket
seekingalpha.com - January 9 at 5:00 PM |
| Biotech Stock Roundup: Updates From INCY & EXEL, APLS & LIFE Surge on Positive Data
finance.yahoo.com - January 8 at 4:23 PM |
| Publicly traded company moves HQ out of Louisville area
www.bizjournals.com - January 8 at 6:51 AM |
| Apellis Pharma files for mixed shelf
seekingalpha.com - January 7 at 8:51 PM |
 | Apellis' Lead Drug Tops Alexion's Blockbuster Soliris in a Pivotal Late-Stage Study
www.fool.com - January 7 at 3:50 PM |
| Here's Why Apellis Pharmaceuticals Stock Jumped as Much as 40.7% Today
www.fool.com - January 7 at 3:50 PM |
| Waltham biotech's drug bests Alexion's blockbuster Soliris in new trial
www.bizjournals.com - January 7 at 3:50 PM |
| Apellis Stock Soars After Head-to-Head Drug Trial Vs Alexion
www.barrons.com - January 7 at 3:50 PM |
 | Apellis Pharmaceuticals Soars as Blood-Drug Test Outperforms Alexion's Therapy
www.thestreet.com - January 7 at 3:50 PM |
 | Why This PNH Study Could Set the Standard for Treatment
www.msn.com - January 7 at 9:54 AM |
| Apellis Pharma's APL-2 successful in PNH study; shares up 49% premarket
seekingalpha.com - January 7 at 9:54 AM |
| Apellis Reports Positive Top-line Results from Phase 3 Head-to-Head Study of Pegcetacoplan (APL-2) Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
finance.yahoo.com - January 7 at 9:54 AM |
| Apellis stock soars on positive data for potential Soliris competitor
finance.yahoo.com - January 7 at 9:54 AM |
| This Biotech Just Topped Alexion's Biggest Moneymaker — And Rocketed
finance.yahoo.com - January 7 at 9:54 AM |
| Here's Why Apellis Pharmaceuticals Fell Today
www.fool.com - December 5 at 6:16 PM |
| Apellis Presents First Data on APL-2 in C3 Glomerulopathy at ASN Kidney Week
finance.yahoo.com - November 8 at 12:38 PM |
| Apellis Pharmaceuticals EPS misses by $0.09
seekingalpha.com - November 5 at 7:57 AM |
| Apellis Pharmaceuticals Reports Third Quarter 2019 Business Update and Financial Results
finance.yahoo.com - November 5 at 7:57 AM |
| Is Apellis Pharmaceuticals, Inc. (APLS) Going to Burn These Hedge Funds?
finance.yahoo.com - October 28 at 1:33 PM |
